Showing results (1531-1540 of 2,361) with videos related to
Sort By:
Pageof 237
Clinical Neuropharmacology|January 18, 2014
Reduction in the free radical status and clinical benefit of repeated intrathecal triamcinolone acetonide application in patients with progressive multiple sclerosisThomas Müller, Thomas Herrling, Sven Lütge, et al.Clinical Neuropharmacology|January 18, 2014
A D1 receptor antagonist, ecopipam, for treatment of tics in Tourette syndromeDonald L Gilbert, Cathy L Budman, Harvey S Singer, et al.Clinical Neuropharmacology|November 6, 2012
Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson diseaseSantiago Perez-Lloret, María Verónica Rey, Nelly Fabre, et al.Clinical Neuropharmacology|November 6, 2012
Tolerability profile of clonidine in the treatment of adults with Tourette syndromeAndrea Eugenio Cavanna, Claudia Selvini, Cristiano Termine, et al.Clinical Neuropharmacology|March 14, 2015
Pet killing as a manifestation of impulse control disorder secondary to pramipexolFederico Micheli, Alejandro Pellene, Daniela Arcushin, et al.Clinical Neuropharmacology|March 14, 2015
Writing tremor secondary to ischemic stroke: a report on a case with a remarkable response to topiramateJuan P Paviolo, Gabriela B Raina, Eugenia Conti, et al.Clinical Neuropharmacology|March 14, 2015
Methylphenidate-induced awake bruxism: a case reportRukiye Çolak Sivri, Ayhan BilgiçClinical Neuropharmacology|December 1, 1989
CV 205-502: safety, tolerance to, and efficacy of increasing doses in patients with Parkinson's disease in a double-blind, placebo crossover studyC W Olanow, E G Werner, L L GaugerClinical Neuropharmacology|October 1, 1989
Hypersexuality with antiparkinsonian therapyR J Uitti, C M Tanner, A H Rajput, et al.Clinical Neuropharmacology|April 18, 2023
The Effect of Adding Curcumin to Sertraline in the Treatment of Severe Major Depressive Disorder: A Randomized, Double-Blind Clinical TrialAli Talaei, Reza Noori, Amir Rezaei Ardani, et al.Pageof 237